THE ANALYSIS STUDY OF ONE-STEP COMPARED WITH TWO-STEP GESTATIONAL DIABETES SCREENING AND PREGNANCY OUTCOMES: A COMPREHENSIVE SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/339y7254Keywords:
Diabetes, gestational, screening, one step, two stepAbstract
Background: Gestational diabetes mellitus (GDM) is a condition of glucose intolerance developed during pregnancy. Many women with GDM experience pregnancy -related complications, which primarily affect the fetus and include macrosomia, congenital malformations, prematurity, neonatal intensive care unit (NICU) admission, and respiratory distress syndrome.
The aim: The aim of this study to show about the analysis study of one-step compared with two step gestational diabetes screening and pregnancy outcomes.
Methods: By the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. This search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed, SagePub, and Sciencedirect were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: Eight publications were found to be directly related to our ongoing systematic examination after a rigorous three-level screening approach. Subsequently, a comprehensive analysis of the complete text was conducted, and additional scrutiny was given to these articles.
Conclusion: Patients undergoing one- and two-step testing had equal rates of LGA infants, despite a greater likelihood of GDM diagnosis and treatment with one-step testing. Our findings favor two-step testing to minimize the increased burden of GDM diagnosis resulting from one-step testing. However, understanding the long-term implications of such a strategy across the life course is critically important to inform the public health path forward.
References
Caissutti C, Khalifeh A, Saccone G, Berghella V. Are women positive for the One Step but negative for the Two Step screening tests for gestational diabetes at higher risk for adverse outcomes Acta Obstet Gynecol Scand. 2018;97(2):122–34.
Hosseini E, Janghorbani M. Systematic review and meta-analysis of diagnosing gestational diabetes mellitus with one-step or two-step approaches and associations with adverse pregnancy outcomes. Int J Gynecol Obstet. 2018;143(2):137–44.
Akinyemi OA, Omokhodion O V, Fasokun ME, Makanjuola D, Ade-Ojo IP, Adeniyi AA. Screening for Gestational Diabetes Mellitus: Is There a Need for Early Screening for All Women in Developing Countries Cureus. 2023;15(2):2–7.
Reddi Rani P, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagnostic Res. 2016;10(4):QE01–4.
Coustan DR, Dyer AR, Metzger BE. One-step or 2-step testing for gestational diabetes: which is better Am J Obstet Gynecol
Utz B, Kolsteren P, De Brouwere V. Screening for gestational diabetes mellitus: Are guidelines from high-income settings applicable to poorer countries Clin Diabetes.
U.S. Preventive Services Task Force. Gestational Diabetes Mellitus, Screening. 2014;32(4):2012–5.
Ramezani Tehrani F, Rahmati M, Farzadfar F, Abedini M, Farahmand M, Hosseinpanah F, et al. One-step versus two-step screening for diagnosis of gestational diabetes mellitus in Iranian population: A randomized community trial. Front Endocrinol (Lausanne). 2023;13(February):1–9.
Vanden Brink H. Dx Criteria by BMI. AcademicOupCom
Satodiya M, Takkar N, Goel P, Kaur J. Comparison of One-Step Versus Two-Step Screening for Diagnosis of GDM in Indian Population: A Randomized Controlled Trial. J Obstet Gynecol India. 2017;67(3):190–5.
Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, et al. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. Obstet Gynecol Surv. 2021;76(8):460–1.
Khalifeh A, Eckler R, Felder L, Saccone G, Caissutti C, Berghella V. One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial. J Matern Neonatal Med. 2020;33(4):612–7.
Saccone G, Caissutti C, Khalifeh A, Meltzer S, Scifres C, Simhan HN, et al. One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials. J Matern Neonatal Med. 2019;32(9):1547–55.
Lee SU, Hong S, Choi SK, Kim SM, Shin JE, Kil KC, et al. Glucose tolerance test with a single abnormal value as a predictor of type 2 diabetes mellitus: a multicenter retrospective study. Sci Rep
Bhavadharini B, Uma R, Saravanan P, Mohan V. Screening and diagnosis of gestational diabetes mellitus - relevance to low and middle income countries. Clin Diabetes Endocrino
Gupta Y, Kalra B, Baruah MP, Singla R, Kalra S. Updated guidelines on screening for gestational diabetes. Int J Womens Health. 2015;7:539–50.
Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;
Moon JH, Jang HC. Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications. Diabetes Metab J. 2022;46(1):3–14.
Brown FM, Wyckoff J. Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes. Curr Diab Rep. 2017;17(10):1–13.
Brady M, Hensel DM, Paul R, Doering MM, Kelly JC, Frolova AI, et al. One-Step Compared With Two-Step Gestational Diabetes Screening and Pregnancy Outcomes: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022;140(5):712–23.
Minschart C, Beunen K, Benhalima K. An update on screening strategies for gestational diabetes mellitus: A narrative review. Diabetes, Metab Syndr Obes. 2021;14:3047–76.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Vennylia Wijaya
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.